AbbVie Inc.'s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered ...
While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback